In addition, RGMa is greatly expressed in CD4+ T cells in experimental autoimmune encephalomyelitis mice, an animal model of multiple sclerosis (MS), and therapeutic inhibition of RGMa improved the clinical symptoms of diseased mice (3, 13, 14). The gene discussed is RGMA; the disease is myeloid sarcoma.